Oberland Capital’s $320 Million Investment in ImmunityBio

Wilson Sonsini Goodrich & Rosati represented ImmunityBio in the transaction.ImmunityBio, Inc., a clinical-stage immunotherapy company announced an up to $320 million royalty financing and equity investment…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now